โ† All Topics / eu

EU 2020 354 entry 16 urate stones

EU_2020_354_entry_16_urate_stones

eu 274 tok en 2026-07-18

EU Reg 2020/354 Part B Entry 16 โ€” Reduction of urate stones formation

Species: Dogs, Cats

Purpose (essential nutritional characteristics): Reduction of urate stones formation โ€” (Dogs) Crude protein โ‰ค 130 g/kg complete feed with a moisture level of 12 % (2) Or Crude protein โ‰ค 220 g/kg complete feed with a moisture level of 12 % (2) and selected protein sources / (Cats) Crude protein โ‰ค 317 g/kg complete feed with a moisture content of 12 % (2)

Duration of use: Up to 6 months, but lifetime use in case of irreversible disturbance of uric acid metabolism

Source: EU Reg 2020/354 Part B (consolidated text per EUR-Lex CELEX:02020R0354, version 2025-04-22). Entry 16 is part of the 44 PARNUT entries in Part B (range 10-72). Cross-references: AAFCO nutrition profiles for chronic kidney disease, cardiac disease, dermatological conditions. FEDIAF nutritional guidelines 2025 provide complementary guidance but do not authorize therapeutic claims โ€” EU 2020/354 is required for products marketed with PARNUT claims.

Notes: This entry is part of the 44-entry block (10-30 + 50-72). Entries 31-49 are not used in the current consolidated text (numbering jumps from 30 to 50). Always consult official EUR-Lex consolidated 2020/354 text when preparing EU-market petitions for products covered by Entry 16.

Sources

  • reg_2020_354_consolidated_20250422.txt